MENU
+Compare
OMER
Stock ticker: NASDAQ
AS OF
May 2 closing price
Price
$7.17
Change
+$0.15 (+2.14%)
Capitalization
416.32M

OMER Omeros Corp Forecast, Technical & Fundamental Analysis

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more

Industry: #Biotechnology
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OMER with price predictions
May 01, 2025

OMER in -1.37% downward trend, declining for three consecutive days on April 29, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where OMER declined for three days, in of 318 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where OMER's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

OMER moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OMER crossed bearishly below the 50-day moving average on April 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for OMER entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OMER's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on OMER as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OMER just turned positive on April 22, 2025. Looking at past instances where OMER's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OMER advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

OMER may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OMER’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.152). P/E Ratio (0.000) is within average values for comparable stocks, (63.512). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.846). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (251.893).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMER’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OMER is expected to report earnings to rise 2.31% to -55 cents per share on August 06

Omeros Corp OMER Stock Earnings Reports
Q2'25
Est.
$-0.55
Q4'24
Beat
by $0.15
Q3'24
Beat
by $0.13
Q2'24
Missed
by $0.27
Q1'24
Missed
by $0.07
The last earnings report on March 31 showed earnings per share of -54 cents, beating the estimate of -68 cents. With 401.44K shares outstanding, the current market capitalization sits at 416.32M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA287.216.69
+2.38%
Tesla
SPY566.768.29
+1.48%
SPDR® S&P 500® ETF
BTC.X96910.070000417.734380
+0.43%
Bitcoin cryptocurrency
GME27.480.05
+0.18%
GameStop Corp
AAPL205.35-7.97
-3.74%
Apple

OMER and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with INM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
-4.49%
INM - OMER
46%
Loosely correlated
+3.86%
MDXG - OMER
41%
Loosely correlated
-8.14%
TGTX - OMER
32%
Poorly correlated
-0.31%
PRME - OMER
32%
Poorly correlated
+0.58%
ACIU - OMER
32%
Poorly correlated
-3.47%
More